EUVIMEDEUVIMED entdecken
Kohortenstudie

Intravenous immunoglobulin for cytomegalovirus-associated thrombocytopenia in immunocompetent children: a retrospective cohort study

Qiji Guo, Yuhang Wu, Hao Xu, Bofei Hu, ZeFeng Shen, Wenchun Fan, Yilei Lao, Daqing Ma, Lisu Huang iD

Infection · 05.11.2026

DOI: 10.1007/s15010-026-03039-8 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Infection, online erschienen am 05.11.2026. Verfasst von Qiji Guo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Children's Hospital, National Clinical Research Center for Children and Adolescents' Health and Diseases, Zhejiang…. Die Arbeit nennt 26 Literaturangaben. Gefördert von: the "Pioneering Leadership + X" Research and Development Plan of Zhejiang Provincial Department of Science and Technology, the “Pioneering Leadership + X” Research and Development Plan of Zhejiang Provincial Department of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cytomegalovirus (CMV)-associated thrombocytopenia can cause clinically important bleeding in young infants, but evidence guiding immunomodulatory treatment is limited. We evaluated the association between intravenous immunoglobulin (IVIG) exposure and recovery and explored whether virologic or hematologic markers modified this association. METHODS: We retrospectively studied 87 immunocompetent children with CMV-associated thrombocytopenia admitted to a tertiary children's hospital from July 2018 through April 2024. IVIG, ganciclovir, and glucocorticoid exposure were modeled as time-dependent covariates in multivariable Cox models. Outcomes were time to platelet recovery (≥ 100 × 10⁹/L) and, among children bleeding at Day 0, time to bleeding recovery. Sensitivity analyses used time-dependent propensity-score matching (TD-PSM) and excluded congenital CMV. RESULTS: 49 children received IVIG. IVIG exposure was associated with faster bleeding recovery (adjusted HR, 3.55; 95% CI, 1.49-8.45; P = 0.004). The platelet-recovery estimate favored IVIG but was statistically uncertain (adjusted HR, 1.75; 95% CI, 0.97-3.17; P = 0.064). Platelet TD-PSM yielded a similar estimate with good measured balance (HR, 1.81; 95% CI, 1.05-3.15; P = 0.034), whereas bleeding TD-PSM was directionally consistent but retained residual imbalance (HR, 1.82; 95% CI, 1.03-3.21; P = 0.039). Formal interaction testing did not show statistically significant effect modification by CMV-IgM, CMV-DNA load, or Day-0 platelet severity for either platelet or bleeding recovery. CONCLUSIONS: Time-dependent IVIG exposure was associated with faster bleeding recovery, whereas the primary platelet-recovery estimate was favorable but less certain. Sensitivity analyses support prospective evaluation, but exploratory biomarker analyses do not establish an IVIG-responsive phenotype.

Schlagwörter

Stichwörter der Autor:innen

CytomegalovirusImmunocompetent childrenIntravenous immunoglobulinPlatelet recoveryThrombocytopenia

Autor:innen und Institutionen

  • Department of Infectious Diseases, Children's Hospital, National Clinical Research Center for Children and Adolescents' Health and Diseases, Zhejiang University School of Medicine, Hangzhou, 310052, China.
  • Zhejiang University School of Medicine, Hangzhou, 310052, China.
  • Children's Hospital, National Clinical Research Center for Children and Adolescents' Health and Diseases, Zhejiang University School of Medicine, 3333 Bin Sheng Road, Hangzhou, 310052, China.
  • Shaoxing Maternity and Child Health Care Hospital, Shaoxing, Zhejiang, China.
  • Zhejiang Provincial Key Laboratory for Cancer Molecular Cell Biology, Life Sciences Institute, Zhejiang University, Hangzhou, 310058, Zhejiang, China.
  • Perioperative and Systems Medicine Laboratory, Department of Anesthesiology, Children's Hospital, National Clinical Research Center for Children and Adolescents' Health and Diseases, Zhejiang University School of Medici…

ORCID-Profile: Lisu Huang

Förderung

  • the "Pioneering Leadership + X" Research and Development Plan of Zhejiang Provincial Department of Science and Technology
  • the “Pioneering Leadership + X” Research and Development Plan of Zhejiang Provincial Department of Science and Technology

Zitieren

APA

Guo, Q., Wu, Y., Xu, H., Hu, B., Shen, Z., Fan, W., Lao, Y., Ma, D., & Huang, L. (2026). Intravenous immunoglobulin for cytomegalovirus-associated thrombocytopenia in immunocompetent children: a retrospective cohort study. Infection. https://doi.org/10.1007/s15010-026-03039-8

Vancouver

Guo Q, Wu Y, Xu H, Hu B, Shen Z, Fan W, et al. Intravenous immunoglobulin for cytomegalovirus-associated thrombocytopenia in immunocompetent children: a retrospective cohort study. Infection. 2026. doi:10.1007/s15010-026-03039-8

BibTeX
@article{Guo2026,
  author = {Guo, Qiji and Wu, Yuhang and Xu, Hao and Hu, Bofei and Shen, ZeFeng and Fan, Wenchun and Lao, Yilei and Ma, Daqing and Huang, Lisu},
  title = {Intravenous immunoglobulin for cytomegalovirus-associated thrombocytopenia in immunocompetent children: a retrospective cohort study},
  journal = {Infection},
  year = {2026},
  doi = {10.1007/s15010-026-03039-8}
}
Kostenlos starten →